About DFE Pharma
DFE Pharma is a company based in Goch (Germany) founded in 2011 was acquired by CVC in September 2019. DFE Pharma operates in a competitive market with competitors including Colorcon, SPI Pharma, Pfanstiehl, Meggle Pharma and JRS Pharma, among others.
- Headquarter Goch, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of DFE Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of DFE Pharma
Detailed funding history for DFE Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in DFE Pharma
DFE Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CVC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mezzanine financing and equity investments are provided by CVC.
|
Locked | Locked | Locked |
Investor details for DFE Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DFE Pharma
Investment portfolio details for DFE Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DFE Pharma
Detailed financials for DFE Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dfe Pharma Comparisons
Peer comparison for DFE Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DFE Pharma
DFE Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Colorcon, SPI Pharma, Pfanstiehl, Meggle Pharma and JRS Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of specialty excipients and corporate-backed venture capital fund focused on healthcare startups
|
|
| Locked | Locked | Locked |
Excipient products and formulations are manufactured for pharmaceutical uses.
|
|
| Locked | Locked | Locked |
APIs, injectable excipients, and bioprocessing solutions are manufactured.
|
|
| Locked | Locked | Locked |
Develops and manufactures pharmaceutical excipients for the industry.
|
|
| Locked | Locked | Locked |
Supplies excipients, coatings, and technical services for health sciences worldwide.
|
Detailed competitors of DFE Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dfe Pharma
Complete news archive for DFE Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DFE Pharma
DFE Pharma was founded in 2011.
DFE Pharma is headquartered in Goch, Germany. It is registered at Goch, North Rhine-westphalia, Germany.
Martti Hedman is the current CEO of DFE Pharma.
DFE Pharma is engaged in the development, manufacturing, and marketing of excipients for oral solid dosage forms and dry powder inhalation formulations. They offer their services for pharmaceutical companies all over the globe for the development of products and also in improving the performance of existing drugs. The company specializes in proprietary excipients such as microcrystalline cellulose, starch and lactose, while they also develop excipients for dry powder inhalations and superdisintegrants. The company is jointly owned by Royal FrieslandCampina and Fonterra, multinational dairy companies.
DFE Pharma's top competitors include Colorcon, Crest Cellulose and Scope Ingredients.
DFE Pharma has 1 investor. Key investors include CVC.